AMCURE GMBH has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are PEPGEN CORP, CBIO LTD and AQUMEN BIOPHARMACEUTICALS K K.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Brazil | 1 | |
#5 | Chile | 1 | |
#6 | China | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 | |
#13 | Philippines | 1 | |
#14 | Singapore | 1 | |
#15 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mier Walter | 12 |
#2 | Lindner Thomas | 12 |
#3 | Haberkorn Uwe | 12 |
#4 | Matzke-Ogi Alexandra | 11 |
#5 | Orian-Rousseau Veronique | 10 |
#6 | Ponta Helmut | 5 |
#7 | Orian-Rousseau Véronique | 5 |
#8 | Matzke Alexandra | 5 |
#9 | Alexandra Matzke-Ogi | 3 |
#10 | Thomas Lindner | 3 |
Publication | Filing date | Title |
---|---|---|
US2017305995A1 | CD44V6-Derived Peptides for Treating Metastasizing Cancer | |
CA2968333A1 | Cd44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases |